Sterling offers a range of early phase chemistry services to ensure quality, purity and efficacy at every stage in your small molecule project. These services include:
Drug discovery
A comprehensive service to increase the chance of success from the start. We provide close scientific collaboration and expertise across each critical stage in the drug discovery process, from initial screening to lead optimisation.
Early scale up
Our approach to early scale up brings together chemistry, analytical, solid state, hazard evaluation and engineering disciplines to support customers in developing robust, safe and scalable processes. Our offering includes services from route scouting to non-GMP supply for toxicology studies and GMP supply for early phase clinical studies.
Analytical services
We support a range of analytical methods based on our customers’ requirements and project stage, these include impurity identification, stability testing, HPLC, NMR and forced degradation studies to name a few.
Sterling’s global network offers facilities specialising in early phase chemistry services as well as full-lifecycle small molecule development and manufacturing services to support your project as it scales. With over 50 years’ industry experience, our customers benefit from access to our wealth of small molecule knowledge and expertise worldwide.
We are more than a traditional CDMO, we are a PDMO® or partnership development and manufacturing organisation. We are dedicated to scientific collaboration with our customers to overcome challenges and ensure success, together. Click to get in touch with an expert about your chemistry services requirements.
